nemu

HOME > NEWS

NEWS

European Patent Office Grants AskAt EP4 Receptor Antagonist Use Patent for the Treatment of Cartilage Disease

2023/01/06

AskAt received a notice of the decision to grant a European patent pursuant to Article 97(1) EPC from the European Patent Office as of December 8, 2022. This grant of European Patent Application No. 14768803.0 (Filing Date: March 19, 2014), is an EP4 receptor antagonist use patent for the treatment of cartilage disease. In addition to Europe, AskAt has received use patents in Japan, the United States, Canada, China, Korea, Mexico, and Russia.

PAGE TOP

Menu